The animal model for testing market is expected to witness significant growth during the forecasted period.
Animal models are commonly used to test the effects of diseases under different conditions and environments. This method of testing is also known as VIVO testing and is conducted by laboratories to study the behaviour or biological system of different animals in different conditions set by the researchers. Animals that have similar anatomical and physiological features to humans are commonly used for animal experimentation. Before a drug is administered to human subjects, the drug undergoes rigorous animal trials to evaluate its toxicity, metabolism, and overall efficacy. These include vertebrate animals such as rodents, primates, dogs, and rabbits. Mice are the most common vertebrate species used in VIVO testing, due to characteristics such as size, ease of handling, fast reproduction, and low cost. They are also known to share 95% of their genes with humans, making them a suitable animal model for VIVO testing purposes and evaluation of the safety and efficacy of the drug candidates at their preclinical stages.
Introduction:
The animal model for testing market growth is attributed to factors such as the increasing burden of zoonotic diseases. The core purpose of animal models is the testing of drug candidates and environmental conditions for analysis and creation of insights, which are further used for the generation of solutions for the future. For instance, during the COVID-19 pandemic, various animals were used for the VIVO testing process, which includes non-human primates such as genetically modified mice (wild-type mice sensitized by Ad5 or AAV vectors consisting of the hACE2 gene), as well as Syrian hamster, ferret, poultry, and domestic animals. Through the use of these animals, laboratories were able to summarize the benefits and defects of the SaRS-CoV-2 receptors and proteases, which eventually led to the creation of several vaccines around the world.
Market Drivers:
Key Players:
Regional Analysis:
The North American region is expected to witness significant growth in the animal model for testing market during the forecasted period of 2024-2029 due to factors such as strong research capabilities and strong healthcare systems affecting the market growth in this region. The use of animals such as mice, rats, guinea pigs, rabbits, and monkeys is common in animal experimentation of diseases and drugs. The support of establishments such as the American Physiological Society, Americans for Medical Progress, and American Society of Animal Science helps increase the effectiveness of animal experimentation, improve preparation for unknown diseases and introduce drugs and products to the general public. The United States is also known for having a strong healthcare infrastructure. For instance, as per Research America, the United States medical and health research and development investment reached US$245.1 billion in 2020, which is an 11.1% increase from 2019. The increase in medical and health R&D in the region provides a major boost to the animal model for the testing market growth during the forecasted period, which provides opportunities in the market for better and innovative methods of VIVO testing and improving the risk reduction of zoonoses.
Segmentation: